Virus-esque nucleus-targeting nanoparticles deliver trojan plasmid for release of anti-tumor shuttle protein
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 320, 253-264
- https://doi.org/10.1016/j.jconrel.2020.01.037
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (81771967, 81822025)
- Sichuan University (ZYYC08002)
- National Program for Support of Top-notch Young Professionals (W02070141)
This publication has 29 references indexed in Scilit:
- The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticlesInternational Journal of Nanomedicine, 2012
- Systemic delivery of lentivirus-mediated secretable TAT-apoptin eradicates hepatocellular carcinoma xenografts in nude miceInternational Journal of Oncology, 2012
- Delivery of Therapeutic Proteins as Secretable TAT Fusion ProductsMolecular Therapy, 2009
- Progress in developing cationic vectors for non-viral systemic gene therapy against cancerBiomaterials, 2008
- Dexamethasone-Conjugated Low Molecular Weight Polyethylenimine as a Nucleus-Targeting Lipopolymer Gene CarrierBioconjugate Chemistry, 2007
- Current status of polymeric gene delivery systems☆Advanced Drug Delivery Reviews, 2006
- Tumor-specific nuclear targeting: Promises for anti-cancer therapy?Drug Resistance Updates, 2006
- Design and development of polymers for gene deliveryNature Reviews Drug Discovery, 2005
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Construction and applications of a highly transmissible murine retrovirus shuttle vectorCell, 1984